ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry DelCOA Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDELHYPOTHETICAL MODEL
Since ’99
−79%
Expense Ratio
0.29%
placeholder
Holdings
225
cap-weighted
Inception
Dec 2022
placeholder
Full Sharpe
-0.26
Ann. Return (LS)
-4.3%
Ann. Volatility
16.5%
Max Drawdown
-83.0%
Test Sharpe ’19–26
-0.33
Test FF5 α (ann.)
-3.6%
vs Fama-French 5
Test FF5 α t-stat
-0.50
not significant
Monthly turnover
20%
of the long leg, per rebalance
Cumulative return (LS)
-79%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.57
what this fund holds
Long leg ann. return
11.3%
buyable, long-only
Long-short Sharpe
-0.26
requires shorting
Bottom bucket ann. return
15.5%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

225 of 225 · 100.0% of book
TickerCompanySectorMarket capWeight
1SNOW
SNOWFLAKE INCTechnology$93.20B
8.58%
2NDAQ
NASDAQ INCFinancial Services$51.83B
4.77%
3AXON
AXON ENTERPRISE INCIndustrials$41.13B
3.78%
4RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
3.64%
5WDAY
WORKDAY INCTechnology$35.76B
3.29%
6HSY
HERSHEY COConsumer Defensive$34.77B
3.20%
7DXCM
DEXCOM INCHealthcare$29.58B
2.72%
8ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
2.45%
9CPRT
COPART INCIndustrials$25.56B
2.35%
10VRSN
VERISIGN INCTechnology$25.27B
2.33%
11MDB
MONGODB INCTechnology$25.12B
2.31%
12MRNA
MODERNA INCHealthcare$24.53B
2.26%
13DLTR
DOLLAR TREE INCConsumer Defensive$24.20B
2.23%
14FSLR
FIRST SOLAR INCTechnology$22.78B
2.10%
15UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
2.09%
16ASTS
AST SPACEMOBILE INCTechnology$22.43B
2.06%
17RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
2.02%
18IFF
INTERNATIONAL FLAVORS & FRAGRANCES INCBasic Materials$19.96B
1.84%
19FTV
FORTIVE CORPTechnology$18.83B
1.73%
20NWSA
NEWS CORPCommunication Services$15.56B
1.43%
21DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
1.36%
22ONTO
ONTO INNOVATION INCTechnology$13.92B
1.28%
23BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
1.26%
24PINS
PINTEREST INCCommunication Services$13.00B
1.20%
25COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
1.11%
26AUR
AURORA INNOVATION INCTechnology$11.88B
1.09%
27BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
1.06%
28HUBS
HUBSPOT INCTechnology$11.49B
1.06%
29HUT
HUT 8 CORPFinancial Services$10.30B
0.95%
30CYTK
CYTOKINETICS INCHealthcare$9.98B
0.92%
31HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.85%
32PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.83%
33WULF
TERAWULF INCFinancial Services$9.00B
0.83%
34TTC
TORO COIndustrials$8.99B
0.83%
35ZG
ZILLOW GROUP INCCommunication Services$7.71B
0.71%
36DBX
DROPBOX INCTechnology$7.14B
0.66%
37IDCC
INTERDIGITAL INCCommunication Services$6.73B
0.62%
38VFC
V F CORPConsumer Cyclical$6.65B
0.61%
39NE
NOBLE CORP PLCEnergy$6.62B
0.61%
40RYN
RAYONIER INCReal Estate$6.56B
0.60%
41LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.60%
42SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.58%
43PATH
UIPATH INCTechnology$6.30B
0.58%
44MYRG
MYR GROUP INCIndustrials$6.10B
0.56%
45RUSHA
RUSH ENTERPRISES INCConsumer Cyclical$5.98B
0.55%
46ERAS
ERASCA INCHealthcare$5.96B
0.55%
47LYFT
LYFT INCTechnology$5.89B
0.54%
48ENPH
ENPHASE ENERGY INCTechnology$5.48B
0.50%
49DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.44%
50IPGP
IPG PHOTONICS CORPTechnology$4.43B
0.41%
51VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.40%
52PI
IMPINJ INCTechnology$4.21B
0.39%
53ACLS
AXCELIS TECHNOLOGIES INCTechnology$4.19B
0.39%
54MAT
MATTEL INCConsumer Cyclical$4.15B
0.38%
55ICUI
ICU MEDICAL INCHealthcare$3.94B
0.36%
56DOCS
DOXIMITY INCHealthcare$3.94B
0.36%
57POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.36%
58TDS
TELEPHONE & DATA SYSTEMS INCCommunication Services$3.90B
0.36%
59RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.35%
60OLED
UNIVERSAL DISPLAY CORPTechnology$3.75B
0.34%
61DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.34%
62CALY
CALLAWAY GOLF COConsumer Cyclical$3.48B
0.32%
63RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.32%
64QTWO
Q2 HOLDINGS INCTechnology$3.43B
0.32%
65SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.30%
66COLM
COLUMBIA SPORTSWEAR COConsumer Cyclical$3.25B
0.30%
67LEU
CENTRUS ENERGY CORPBasic Materials$3.07B
0.28%
68AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.28%
69FRSH
FRESHWORKS INCTechnology$3.01B
0.28%
70RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.27%
71DAN
DANA INCConsumer Cyclical$2.87B
0.26%
72LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.26%
73HOG
HARLEY-DAVIDSON INCConsumer Cyclical$2.80B
0.26%
74CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.26%
75VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.25%
76TNET
TRINET GROUP INCIndustrials$2.74B
0.25%
77VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.25%
78PTON
PELOTON INTERACTIVE INCConsumer Cyclical$2.55B
0.23%
79IMNM
IMMUNOME INCHealthcare$2.53B
0.23%
80PGNY
PROGYNY INCHealthcare$2.50B
0.23%
81NRIX
NURIX THERAPEUTICS INCHealthcare$2.40B
0.22%
82BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.22%
83AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.22%
84BHVN
BIOHAVEN LTDHealthcare$2.32B
0.21%
85IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.21%
86SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.21%
87AGL
AGILON HEALTH INCHealthcare$2.17B
0.20%
88PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.19%
89CDNA
CAREDX INCHealthcare$2.05B
0.19%
90SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.19%
91AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.18%
92CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.17%
93MQ
MARQETA INCTechnology$1.85B
0.17%
94NVCR
NOVOCURE LTDHealthcare$1.84B
0.17%
95SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.17%
96BL
BLACKLINE INCTechnology$1.78B
0.16%
97ASAN
ASANA INCTechnology$1.77B
0.16%
98ZYME
ZYMEWORKS INCHealthcare$1.77B
0.16%
99ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.16%
100FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.15%
101TE
T1 ENERGY INCIndustrials$1.63B
0.15%
102INVA
INNOVIVA INCHealthcare$1.60B
0.15%
103VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.15%
104NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.15%
105INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.13%
106TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.13%
107MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.13%
108ARLO
ARLO TECHNOLOGIES INCBasic Materials$1.45B
0.13%
109YELP
YELP INCCommunication Services$1.44B
0.13%
110HLX
HELIX ENERGY SOLUTIONS GROUP INCEnergy$1.41B
0.13%
111FMC
FMC CORPBasic Materials$1.40B
0.13%
112AI
C3AI INCTechnology$1.37B
0.13%
113CXM
SPRINKLR INCTechnology$1.37B
0.13%
114BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.12%
115FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.12%
116CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.11%
117MMI
MARCUS & MILLICHAP INCReal Estate$1.18B
0.11%
118SDGR
SCHRODINGER INCHealthcare$1.14B
0.11%
119CRTO
CRITEO SACommunication Services$1.13B
0.10%
120UPWK
UPWORK INCIndustrials$1.12B
0.10%
121EYPT
EYEPOINT INCHealthcare$1.12B
0.10%
122PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.09%
123KURA
KURA ONCOLOGY INCHealthcare$964M
0.09%
124ANNX
ANNEXON INCHealthcare$950M
0.09%
125WGO
WINNEBAGO INDUSTRIES INCConsumer Cyclical$868M
0.08%
126REPL
REPLIMUNE GROUP INCHealthcare$859M
0.08%
127MATW
MATTHEWS INTERNATIONAL CORPIndustrials$857M
0.08%
128CYRX
CRYOPORT INCIndustrials$832M
0.08%
129CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.07%
130WLKP
WESTLAKE CHEMICAL PARTNERS LPBasic Materials$776M
0.07%
131BBNX
BETA BIONICS INCHealthcare$771M
0.07%
132KRO
KRONOS WORLDWIDE INCBasic Materials$757M
0.07%
133IBTA
IBOTTA INCTechnology$734M
0.07%
134AURA
AURA BIOSCIENCES INCHealthcare$723M
0.07%
135SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.06%
136PKE
PARK AEROSPACE CORPIndustrials$677M
0.06%
137SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.06%
138MNTN
MNTN INCTechnology$661M
0.06%
139CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.06%
140EVH
EVOLENT HEALTH INCHealthcare$654M
0.06%
141ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.06%
142HY
HYSTER-YALE INCIndustrials$591M
0.05%
143PUBM
PUBMATIC INCTechnology$591M
0.05%
144NGNE
NEUROGENE INCHealthcare$590M
0.05%
145ETD
ETHAN ALLEN INTERIORS INCConsumer Cyclical$580M
0.05%
146MLR
MILLER INDUSTRIES INCConsumer Cyclical$566M
0.05%
147EGY
VAALCO ENERGY INCEnergy$553M
0.05%
148WNC
WABASH NATIONAL CORPIndustrials$547M
0.05%
149ORN
ORION GROUP HOLDINGS INCIndustrials$518M
0.05%
150ARVN
ARVINAS INCHealthcare$517M
0.05%
151SPIR
SPIRE GLOBAL INCIndustrials$488M
0.04%
152SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.04%
153TITN
TITAN MACHINERY INCIndustrials$446M
0.04%
154SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.04%
155BNED
BARNES & NOBLE EDUCATION INCConsumer Cyclical$437M
0.04%
156CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.04%
157ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.04%
158CLFD
CLEARFIELD INCTechnology$416M
0.04%
159MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.04%
160ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.04%
161EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.04%
162VHI
VALHI INCBasic Materials$393M
0.04%
163STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.04%
164UPB
UPSTREAM BIO INCHealthcare$382M
0.04%
165WEYS
WEYCO GROUP INCConsumer Cyclical$374M
0.03%
166ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.03%
167STRT
STRATTEC SECURITY CORPConsumer Cyclical$344M
0.03%
168MTRX
MATRIX SERVICE COIndustrials$342M
0.03%
169RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.03%
170VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.03%
171MSB
MESABI TRUSTBasic Materials$320M
0.03%
172VELO
VELO3D INCTechnology$316M
0.03%
173MKTW
MARKETWISE INCTechnology$314M
0.03%
174OSS
ONE STOP SYSTEMS INCTechnology$313M
0.03%
175BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.03%
176FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.03%
177ALCO
ALICO INCConsumer Defensive$304M
0.03%
178TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.03%
179ASLE
AERSALE CORPIndustrials$286M
0.03%
180TSSI
TSS INCTechnology$274M
0.03%
181AVNW
AVIAT NETWORKS INCTechnology$269M
0.02%
182TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.02%
183ALMU
AELUMA INCTechnology$267M
0.02%
184SVCO
SILVACO GROUP INCTechnology$260M
0.02%
185TBCH
TURTLE BEACH CORPTechnology$258M
0.02%
186VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.02%
187ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.02%
188QUIK
QUICKLOGIC CORPTechnology$237M
0.02%
189ONEW
ONEWATER MARINE INCConsumer Cyclical$224M
0.02%
190KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.02%
191KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.02%
192ALTG
ALTA EQUIPMENT GROUP INCIndustrials$208M
0.02%
193SRI
STONERIDGE INCConsumer Cyclical$197M
0.02%
194COOK
TRAEGER INCConsumer Cyclical$193M
0.02%
195EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.02%
196KVHI
KVH INDUSTRIES INCTechnology$178M
0.02%
197LEE
LEE ENTERPRISES INCConsumer Cyclical$175M
0.02%
198ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.02%
199RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
200HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
201CHPT
CHARGEPOINT HOLDINGS INCConsumer Cyclical$146M
0.01%
202ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
203PMN
PROMIS NEUROSCIENCES INCHealthcare$136M
0.01%
204DMRC
DIGIMARC CORPTechnology$133M
0.01%
205AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
206JYNT
JOINT CORPHealthcare$127M
0.01%
207VATE
INNOVATE CORPIndustrials$123M
0.01%
208SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.01%
209UFI
UNIFI INCConsumer Cyclical$118M
0.01%
210SSTI
SOUNDTHINKING INCTechnology$111M
0.01%
211MHH
MASTECH DIGITAL INCIndustrials$89M
0.01%
212GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.01%
213RLYB
RALLYBIO CORPHealthcare$87M
0.01%
214DLHC
DLH HOLDINGS CORPIndustrials$80M
0.01%
215LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.01%
216ACET
ADICET BIO INCHealthcare$76M
0.01%
217ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.01%
218BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.01%
219TISI
TEAM INCIndustrials$75M
0.01%
220BGSF
BGSF INCIndustrials$65M
0.01%
221BRID
BRIDGFORD FOODS CORPConsumer Defensive$59M
0.01%
222LNZA
LANZATECH GLOBAL INCIndustrials$56M
0.01%
223TACT
TRANSACT TECHNOLOGIES INCTechnology$54M
0.00%
224ACFN
ACORN ENERGY INCTechnology$51M
0.00%
225TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.09T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
32.4%
Healthcare
25.6%
Industrials
11.5%
Consumer Cyclical
7.4%
Consumer Defensive
6.6%
Financial Services
6.5%
Communication Services
5.4%
Basic Materials
2.9%
Energy
0.8%
Real Estate
0.7%

Portfolio Style

Size × value map of the long-leg book

225 classified
Value
Blend
Growth
Large
Mid
Small
4%4
31%19
32%20
3%16
7%30
6%28
1%40
1%23
1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 88% toward Large, 68% toward Growth. +15% unclassified (27 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt88% → Large
SmallLarge
Value ↔ growth tilt68% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 225 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
4
Failed
1
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 225 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.4 (95% CI 1.0-1.7)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
13.4%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.39x
within
parametric
1.24x
within
cornish fisher
1.20x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2005
Before publication (pre-2005)
-0.24
Sharpe · -4.7% p.a.
January 1999December 2005 · 84 mo
Since publication
-0.27
Sharpe · -4.1% p.a.
January 2006July 2026 · 247 mo
Change in Sharpe−0.03Sharpe weakened since publication

Annual return moved the other way (+0.6pp), so Sharpe and return disagree here — the change is partly a shift in volatility rather than in return.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
23%
6 of 26 3-year windows made money
Worst window
-1.53
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
-0.26
Dispersion
0.52
Best window
0.96

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.23.0%3.2%
3 yearsp.a.15.4%-18.2%
5 yearsp.a.10.9%-8.8%
10 yearsp.a.14.9%-8.9%
Since inceptionp.a.9.7%-5.5%
Calendar years
YearLong legLong-short
20267 mo16.8%10.2%
202519.1%-23.2%
20246.5%-38.5%
202362.1%15.5%
2022-29.3%13.8%
202121.3%-6.1%
202036.2%-15.8%
201925.9%-6.5%
2018-10.6%-10.7%
201717.9%-17.9%
201623.7%18.9%
2015-4.5%-6.1%
201411.2%-6.2%
201341.4%-8.5%
201217.5%12.4%
20113.6%4.7%
201019.7%9.5%
200939.9%-14.6%
2008-38.4%16.8%
20078.3%-23.1%
200619.2%-3.9%
20050.3%-11.9%
20043.3%-10.9%
200354.4%14.4%
2002-41.0%-23.5%
2001-15.5%-7.3%
2000-4.7%21.6%
199952.6%-19.1%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDEL
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2022-12-03 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.09T

Methodology

The Foundry DelCOA Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a DelCOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.